Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)

Clinical trial NCT04923802 · TERMINATED

Trial details

NCT number: NCT04923802
Sponsor: GeneCast Biotechnology Co., Ltd.
Status: TERMINATED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Neoantigen Next-generation Sequencing Biomarker

Start date: 2021-06-24
Primary completion: 2021-12-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.